These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 29969453)
1. Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design. Wada H; Shimizu A; Osada T; Tanaka Y; Fukaya S; Sasaki E PLoS One; 2018; 13(7):e0199249. PubMed ID: 29969453 [TBL] [Abstract][Full Text] [Related]
2. Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer. Liu W; Zhai M; Wu Z; Qi Y; Wu Y; Dai C; Sun M; Li L; Gao Y Amino Acids; 2012 Jun; 42(6):2257-65. PubMed ID: 21710262 [TBL] [Abstract][Full Text] [Related]
3. H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Firat H; Garcia-Pons F; Tourdot S; Pascolo S; Scardino A; Garcia Z; Michel ML; Jack RW; Jung G; Kosmatopoulos K; Mateo L; Suhrbier A; Lemonnier FA; Langlade-Demoyen P Eur J Immunol; 1999 Oct; 29(10):3112-21. PubMed ID: 10540322 [TBL] [Abstract][Full Text] [Related]
4. [Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66]. Jin S; Wang Y; Wang SJ; Zhang HZ; Li MX; Chen Y; Ge HL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):233-6, 242. PubMed ID: 15766414 [TBL] [Abstract][Full Text] [Related]
5. DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens. Rice J; Dunn S; Piper K; Buchan SL; Moss PA; Stevenson FK Cancer Res; 2006 May; 66(10):5436-42. PubMed ID: 16707472 [TBL] [Abstract][Full Text] [Related]
6. A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo. Tu SH; Huang HI; Lin SI; Liu HY; Sher YP; Chiang SK; Chong P; Roffler S; Tseng GC; Chen HW; Liu SJ J Immunother; 2012 Apr; 35(3):235-44. PubMed ID: 22421941 [TBL] [Abstract][Full Text] [Related]
7. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1. Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice. Song S; Wang F; He X; He Y; Li D; Sun S Vaccine; 2007 Jun; 25(25):4853-60. PubMed ID: 17418455 [TBL] [Abstract][Full Text] [Related]
9. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612 [TBL] [Abstract][Full Text] [Related]
10. A novel vaccine containing EphA2 epitope and LIGHT plasmid induces robust cellular immunity against glioma U251 cells. Chen H; Yuan B; Zheng Z; Liu Z; Wang S; Liu Y Cell Immunol; 2011; 272(1):102-6. PubMed ID: 22032907 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel Lck-derived T helper epitope long peptides applicable for HLA-A2(+) cancer patients as cancer vaccine. Matsueda S; Shichijo S; Nagata S; Seki C; Yamada A; Noguchi M; Itoh K Cancer Sci; 2015 Nov; 106(11):1493-8. PubMed ID: 26331453 [TBL] [Abstract][Full Text] [Related]
12. Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice. Lin SI; Huang MH; Chang YW; Chen IH; Roffler S; Chen BM; Sher YP; Liu SJ Cancer Lett; 2016 Jul; 377(2):126-33. PubMed ID: 27130449 [TBL] [Abstract][Full Text] [Related]
13. A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model. Sher YP; Lin SI; Chen IH; Liu HY; Lin CY; Chiang IP; Roffler S; Chen HW; Liu SJ Oncotarget; 2016 Jan; 7(1):671-83. PubMed ID: 26621839 [TBL] [Abstract][Full Text] [Related]
14. Peptide FLNPDVLDI of heparanase is a novel HLA-A2-restricted CTL epitope and elicits potent immunological antitumor effects in vitro with an 8-branched design. Zhang J; Yang J; Fan D; Tao H; Wang H; Yu T Oncol Rep; 2013 May; 29(5):1955-61. PubMed ID: 23503586 [TBL] [Abstract][Full Text] [Related]
15. Identification of an HLA-A*0201-restrictive CTL epitope from MUC4 for applicable vaccine therapy. Wu J; Wei J; Meng K; Chen J; Gao W; Zhang J; Xu Z; Miao Y Immunopharmacol Immunotoxicol; 2009; 31(3):468-76. PubMed ID: 19555216 [TBL] [Abstract][Full Text] [Related]
16. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay. Pass HA; Schwarz SL; Wunderlich JR; Rosenberg SA Cancer J Sci Am; 1998; 4(5):316-23. PubMed ID: 9815296 [TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Cytotoxic T Lymphocyte Epitopes of Drug- Resistance Related Protein InhA from Mycobacterium tuberculosis. Li D; Dou Z; Wu Y; Qi Y; Chen J; Gao Y Protein Pept Lett; 2020; 27(11):1141-1150. PubMed ID: 32370703 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis. Duan Z; Li D; Jia Q; Xu J; Chen X; Xu Z; Liu H; Chen B; Wen J Microbiol Immunol; 2015 Dec; 59(12):705-15. PubMed ID: 26577013 [TBL] [Abstract][Full Text] [Related]
19. Identification of human leukemia antigen A*0201-restricted epitopes derived from epidermal growth factor pathway substrate number 8. Tang B; Zhou W; Du J; He Y; Li Y Mol Med Rep; 2015 Aug; 12(2):1741-52. PubMed ID: 25936538 [TBL] [Abstract][Full Text] [Related]
20. Screening and Identification of an H-2K Ma RX; Cheng LF; Ying QK; Liu RR; Ma TJ; Zhang XX; Liu ZY; Zhang L; Ye W; Zhang FL; Xu ZK; Wang F; Wu XA Front Cell Infect Microbiol; 2016; 6():151. PubMed ID: 27933274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]